Le traitement à la dopamine atténue aussi les symptômes de la maladie d'Alzheimer, démontre cette équipe du RIKEN Center for ...

Les différents traitements hormonaux substitutifs (THS) de la ménopause présentent des risques différents, conclut cette analyse menée à l’Université d'Uppsala de 7 traitements hormonaux différents. L ...

Cette équipe de la Cleveland Clinic (Ohio) confirme le lien déjà suggéré entre les substituts du sucre et un risque accru de crise cardiaque et d'accident vasculaire cérébral (AVC). La recherche, ...

Piper Sandler 36 th Annual Healthcare Conference The live and archived webcast of the presentations can be accessed in the Investors section of the Company’s website here.

Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today ...

“Every year, NobleCon showcases emerging growth companies from a variety of industries to a relevant investor audience,” said Dr. Musunuri. “I look forward to sharing an update on our clinical ...

Each presentation will be webcast live and may be accessed through a link on the Investors section of the Company’s website. Archived versions of the webcasts will also be available on the Investors ...

A live webcast of the presentation will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with ...

To arrange a one-on-one meeting, please contact your Citi representative or email cdu@ymabs.com.

About Recce Pharmaceuticals Ltd Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health problems of ...

Apellis Pharmaceuticals, Inc., (Nasdaq: APLS) today announced that the company will participate in the following December investo ...

Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic disorders. On track to report topline data ...